Beware the Death Panel, While Obama Remains In Office

By Sept. 17, the Food and Drug Administration (FDA) is to announce whether they will withdraw their 2008 recommendation of Avastin for breast cancer treatment; this sets off new attention to the reality that no one can trust any Federal medical action, while Obama remains in office, and his Nazi Obamacare remains in effect. His "Affordable Health Care for America Act" was forced through, for the express purpose of shortening lives and protecting HMOs' money. Both these purposes will be served if the FDA revokes its OK of Avastin for breast cancer.

Obamacare was modelled on Tony Blair's 1999 death panel, NICE—National Institute for Health and Clinical Excellence. David Vitter (R-Louisiana) has spoken out on the risk of "rationing care," involved in the FDA Avastin disapproval question. The particulars are the following.

The drug bevacizumab, patented as Avastin by Genentech (owned by Roche, based in Switzerland), acts to deter angiogenesis, which is the body's formation of blood vessels serving cancerous masses. The idea is to kill-off the tumor's blood support system. It is used against cancer in the colon, lung, kidney and brain. In 2008, on a fast-track decision, the FDA gave Avastin its recommendation for breast cancer treatment as well.

However, on July 20, the Oncologic Drugs Advisory Committee—one of 49 such specialty advice committees of the FDA, voted 12 to 1 to recommend that the FDA decide to revoke its official "indication," that advanced breast cancer victims will benefit from bevacizumab. The Committee said, according to mepagetoday.com, that Avastin, "when added to standard chemotherapy, does not extend progression-free survival long enough to be clinically meaningful in HER-2 negative, metastatic breast cancer..." (medpagetoday.com) What they mean by not 'long enough,' is that patients treated with this drug regimen—according to the studies to date—will live from one to 11 months longer than if they didn't get the treatment. So, 30 to 330 days of life is considered not clinically meaningful.

"I shudder at the thought of a government panel assigning a value to a day of a person's life," said Sen. Vitter (R-LA), to the London Telegraph. "It is sickening to think that care would be withheld from a patient simply because their life is not deemed valuable enough. I fear this is the beginning of a slippery slope leading to more and more rationing under the government takeover of health care that is being forced on the American people."

Lyndon LaRouche was even more blunt than Sen. Vitter. LaRouche declared today, "This is exactly the genocide I warned about, dating back to my April 11, 2009 international webcast. This is why Obama gets the moustache. He is the reincarnation of Adolph Hitler. If the FDA decision is ratified, this is the first step towards death camps."

Avastin costs $8,000 a month for breast cancer treatment. If the FDA advises against it, Medicare won't cover it. The HMO cartel will refuse to pay for it, and "save" $8,000-$88,000 per woman with breast cancer, by having her die early. Physicans can still legally prescribe it "off-label;" it will just be for the rich.

NICE has not issued a decision on Avastin for breast cancer.